Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Epithelial_ovarian_cancer
|
| gptkbp:associated_with |
gptkb:Lynch_syndrome
endometrial cancer estrogen exposure |
| gptkbp:can_lead_to |
metastasis
|
| gptkbp:caused_by |
gptkb:fandom
fatigue weight loss pelvic pain |
| gptkbp:end_of_life |
varies by stage
higher in early stages |
| gptkbp:genetic_diversity |
gptkb:KRAS
gptkb:PTEN PI K3 CA |
| https://www.w3.org/2000/01/rdf-schema#label |
Endometrioid carcinoma
|
| gptkbp:is_associated_with |
poor prognosis in advanced stages
|
| gptkbp:is_characterized_by |
glandular differentiation
|
| gptkbp:is_linked_to |
genetic predisposition
|
| gptkbp:is_often_associated_with |
postmenopausal women
|
| gptkbp:is_often_used_in |
gptkb:philosopher
African American women Asian women |
| gptkbp:is_protected_by |
healthy lifestyle
regular screenings |
| gptkbp:is_related_to |
infertility
endometrial hyperplasia |
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:number_of_stages |
Stage I
Stage II Stage III Stage IV |
| gptkbp:occurs_in |
other cancers
|
| gptkbp:recognizes |
gptkb:MRI
CT scan hysteroscopy transvaginal ultrasound |
| gptkbp:risk_factor |
obesity
hormonal imbalance |
| gptkbp:scientific_classification |
Type I endometrial cancer
Type II endometrial cancer |
| gptkbp:social_responsibility |
imaging studies
biopsy depends on stage depends on grade |
| gptkbp:symptoms |
abnormal vaginal bleeding
|
| gptkbp:treatment |
gptkb:hospital
gptkb:vaccine radiation therapy chemotherapy targeted therapy hormonal therapy depends on response to therapy |
| gptkbp:type_of |
endometrial carcinoma
|